FDA report “Cubist Pharmaceuticals, Inc.is voluntarily recalling nine lots of CUBICIN (daptomycin for injection) to the user level following complaints of foreign particulate matter in reconstituted vials. Refer to thefor a list of affected products.”
Voluntarily recall of a further nine batches of daptomycin for injection http://ctt.ec/eQeuM+ @ivteam #ivteam
Other intravenous and vascular access resources that may be of interest (External links – IVTEAM has no responsibility for content).
- Guide for intravenous chemotherapy and associated vascular access devices from Macmillan.
- CancerUK IV chemotherapy information.